期刊文献+

卵巢上皮癌中CD44基因mRNA内含子9的检测及临床意义

Detection of intron 9 in CD44 gene transcriptsin ovarian epithelial cancerand its clinical significance
暂未订购
导出
摘要 目的 :研究卵巢上皮癌中CD44基因mRNA内含子 9的滞留情况及其临床意义。方法 :采用半定量RT PCR方法检测不同卵巢组织中CD44基因mRNA内含子 9的滞留率及相对含量。结果 :内含子 9在正常卵巢组织中无滞留 ;在卵巢良性、交界性、恶性上皮性瘤中滞留率及相对含量分别为 3 6.67%和 8.3 7% ,87.50 %和86.87% ,93 .3 3 %和 91.17% ;恶性和交界性上皮性卵巢瘤中内含子 9的滞留率及相对含量明显高于良性上皮性卵巢肿瘤 (P <0 .0 1) ;不同组织学类型和临床分期内含子 9的滞留率和相对含量无显著性差异 (P >0 .0 5)。结论 :检测内含子 Objective: To investigate unusualretenti on ofintron 9 in CD44 gene transcripts in ovarian epithelial cancer and its cli nical significance. Methods: Semi-quantitatively reverse tran scription-polymerase chain reaction (RT-PCR) was used to analyzethe retentio n rate and relativecontent of intron 9 in CD44 gene transcripts in 30 cases ofmalignant ovarian epithelialcancer , 8 of ovarian borderline tumors, 30 of be nign ovariantumorsand 10 ofnormal ovary.Results: The r etention of intron 9 in CD44 gene transcripts was not foundin normal ovarian t issue.The retentionrates and relative contents of intron 9 in ovarian benign , borderline, and malignant tumor were 36.7%and 8.37%, 87.50% and 86.87%, 93 .33% and91.17%,respectively. The retention of intron 9 in ovarian borderlineand malignant tumors were significantly higher than that in benign tumors (P <0.01).There was similar retentionof intron 9 in different histological type s and clinical stages ofovariantumors. No correlation was found between theclinical stages or histological types of ovarian tumors and the retention of int ron 9 (P>0.05).Conclusion: Detection of retention ofin tron 9 may be a molecular diagnostic tool for ovarian carcinoma.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2004年第1期86-88,共3页 Journal of China Medical University
关键词 卵巢肿瘤 CD44抗原 基因表达 ovarian tumor CD44 antigen gene expressio n
  • 相关文献

参考文献10

  • 1[1]Yasuhiro Matsumura, Makoto Sugiyama, Shoko Maosumura, et al. Unusual retention of introns in CD44 gene transcripts on bladder cancer provides new diagnostic and clinical oncological opportunities[J]. J Pathol,1995, 177(1): 11-20.
  • 2[2]Kazuhiro Yashida, John Bolod Deoku, Takashi Sugino, et al. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors[J]. Cancer Res,1995, 55(18): 4273-4277.
  • 3[3]Koopman G, Heider K, Horst E, et al. Activated human lymphocytes and aggressive non-Hodgkin's-associated variant of CD44[J]. J Exp. Med, 1993, 177(4): 897-904.
  • 4[4]Screaton GR, Bell MV, Jackson DG, et al. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1(CD44) homing receptor[J]. J Biol Chem, 1993, 268(21): 12235-12238.
  • 5[5]Tolg C, Hofman M, Erdich P, et al. Splicing choice from ten variant exon establishes CD44 variability[J]. Nucleic Acids Res,1993, 21(7): 1225-1229.
  • 6[6]Stamenkovik I, Aruffo Amiot M. The hematopoitic and epithelial forms of CD44 are distinct polypetieds with different adhesion potentials for hyaluronate-bearing cells[J]. EMBO J,1991, 10(2): 343-349.
  • 7[7]Stamenkovik I, Amiot M, Pesand JM, et al. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family[J]. Cell, 1989, 56(6): 1057-1062.
  • 8[8]Pericle F, Sconocchia G, Titus JA, et al. CD44 is a cytotoxic triggering molecule on human polymorphonuclear cell[J]. J Immunol, 1996, 157(10): 4657-4663.
  • 9[9]Cannistra SA, Kansas GS, Viloff J, et al. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44 H[J]. Cancer Res, 1993, 53(16): 3830-3841.
  • 10[10]Thamas strobel, Swanson L, Stephen A, et al. In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in mude mice : a novel role for CD44 in the process of peritoneal implantation[J]. Cancer Res, 1997, 57(9): 1229-1232.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部